MedX Health Corp (TSXV:MDX)
Canada
· Delayed Price · Currency is CAD | Market Cap | 25.65M |
| Revenue (ttm) | 494.04K |
| Net Income (ttm) | -4.32M |
| Shares Out | 301.79M |
| EPS (ttm) | -0.02 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,000 |
| Average Volume | 128,915 |
| Open | 0.0900 |
| Previous Close | 0.0900 |
| Day's Range | 0.0900 - 0.0900 |
| 52-Week Range | 0.0400 - 0.1000 |
| Beta | 1.92 |
| RSI | 58.36 |
| Earnings Date | Jun 3, 2025 |
About MedX Health
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It also provides scope kits, SIAscope, a clinical camera; and DermSecure,... [Read more]
Financial Performance
In 2024, MedX Health's revenue was 489,698, an increase of 7.37% compared to the previous year's 456,088. Losses were -3.65 million, -20.25% less than in 2023.
Financial StatementsNews
MedX Announces the Engagement of Market Maker Consultant
MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announces today the engagement of Red Cloud Securities Inc. (“Red Cloud”) to provide market making services to the Compa...
MedX Announces the Engagement of Market Maker Consultant
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announces today the engagement of Red Cloud Securities Inc. (“Red Cloud”) to provide market making servi...
MedX Announces Final Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Releases dated April 7, and May 22, 2025, announcing an Initial Closin...
MedX Announces Final Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Releases dated April 7, and May 22, 2025, announcing a...
MedX Announces Further Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, announcing an Initial Clo...
MedX Health, Vitamed Biomedical, and Medispa Partner to Expand Teledermatology Services Across Italy
MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce a strategic collaboration in the Italian healthcare market be...
MedX Health, Vitamed Biomedical, and Medispa Partner to Expand Teledermatology Services Across Italy
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce a strategic collaboration in the Italian heal...
MedX Health and Health Partners Sign Commercial Agreement Following Successful UK Pilot
MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), the global leader in teledermatology solutions, is pleased to announce the signing of a commercial contract with Health ...
MedX Health and Health Partners Sign Commercial Agreement Following Successful UK Pilot
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), the global leader in teledermatology solutions, is pleased to announce the signing of a commercial contr...
MedX Announces Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, when it announced the Initial Closing of ...
MedX Announces Extension of Non-Brokered Private Placement
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that, further to its Press Release dated April 7, 2025, when it announced the Ini...
MedX announces Initial Closing of Non-Brokered Private Placement
MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it has completed the Initial Closing of the Non-brokered Private Placement to accredited inv...
MedX announces proposed Non-Brokered Private Placement to raise up to $2,500,000 and Stock Option Grants
MISSISSAUGA, Ontario — MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) is pleased to announce that it is proposing to raise up to $2,500,000 by way of a Non-Brokered Private Placement of up t...
MedX Announces Intention to Seek Acceptance for Amendment to Warrants
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces its intention to seek acceptance for an amendment to terms for warrants issued in connection with 2020 private placeme...
MedX Health Announces Board Changes
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health adds capital investor experience to its Board with the appointment of two new Directors.
MedX Health and PharmaChoice Announce Agreement to Launch MedX Teledermatology Screening Platform Across Canada
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health and PharmaChoice announce agreement to launch commercialization pilot project for MedX's DermSecure teledermatology screening pl...
MedX Health Announces Final Closing of Secured Convertible Debenture Financing
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces final closing of its previously announced Secured Convertible Debentures financing.
MedX Announces First Closing of Secured Convertible Debenture Financing
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces first closing of Secured Convertible Debenture financing for $765,000.
MedX Announces Proposed Secured Convertible Debenture Financing
MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that it is proposing to complete a private ...
MedX Announces Final Closing of Issuance of Series III Convertible Loan Notes
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces closing of private placement of its Series III Convertible Loan Notes for a total of $1.1 Million.
MedX Health Confirms Further Interim Closing and Application for Further Extension of Price Protection for Private Placement Convertible Loan Note Financing
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces closing of further subscriptions for $350,000 and application for extension of price protection for private placement ...
MedX Health Applies for Extension of Price Protection for Private Placement Convertible Loan Note Financing
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health applies for extension of price protection for private placement.
MedX Announces Closing of First Tranche of Non-Brokered Private Placement of Convertible Loan Notes and Also Announces Application for Warrant Extension
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces the closing of the first tranche of its non-brokered private placement of convertible loan notes.
MedX Announces Amendment to the Terms of Previously Announced Non-Brokered Private Placement of Series III Convertible Loan Notes
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces amendment to terms of its non-brokered private placement of up to $4 million convertible loan notes.
MedX Announces Non-Brokered Private Placement of Series III Convertible Loan Notes to Raise Up To $4 million and Also Grant of Stock Options
MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $MDX #SkinCancer--MedX Health announces non-brokered private placement of up to $4 million of convertible loan notes.